Suppr超能文献

加速的依赖融合的内体逃逸可提高递送的酶货物的活性。

Hastened Fusion-Dependent Endosomal Escape Improves Activity of Delivered Enzyme Cargo.

作者信息

Vázquez-Maldonado Angel Luis, Chen Teresia, Rodriguez Diego, Zoltek Madeline, Schepartz Alanna

机构信息

Department of Chemistry, University of California, Berkeley, California 94720, United States.

Department of Molecular and Cellular Biology, University of California, Berkeley, California 94720, United States.

出版信息

ACS Cent Sci. 2025 Mar 18;11(4):574-582. doi: 10.1021/acscentsci.5c00012. eCollection 2025 Apr 23.

Abstract

There is enormous interest in strategies to traffic biologics into the mammalian cell cytosol. Not only must these materials reach the appropriate cellular locale intact and in therapeutically relevant concentrations, they must also retain activity upon arrival. The question of residual activity is especially critical when delivery involves the late endocytic pathway, whose acidic environment can denature and/or degrade internalized material. ZF5.3 is a compact mini-protein that escapes efficiently from late endocytic vesicles, with or without covalently linked protein cargo. Here, we redesign the sequence of ZF5.3 to hasten the timing of endosomal escape. The new mini-protein we describe, AV5.3, escapes earlier than ZF5.3 along the endocytic pathway with no loss in efficiency, with or without enzyme cargo. More importantly, earlier endosomal escape translates into higher enzymatic activity of a pH-sensitive enzyme upon arrival in the cytosol. Delivery of the pH-sensitive enzyme DHFR with AV5.3 results in substantial catalytic activity in the cytosol, whereas delivery with ZF5.3 does not. The activity of delivered AV5.3-DHFR successfully rescues a DHFR deletion in CHO cells. AV5.3 represents an improved strategy for the efficient and direct delivery of active therapeutic proteins and enzymes.

摘要

将生物制剂运输到哺乳动物细胞胞质溶胶中的策略引起了极大的关注。这些物质不仅必须完整地到达合适的细胞位置并达到治疗相关浓度,而且到达后还必须保持活性。当递送涉及晚期内吞途径时,残余活性问题尤为关键,因为其酸性环境会使内化物质变性和/或降解。ZF5.3是一种紧密的小蛋白,无论有无共价连接的蛋白货物,它都能有效地从晚期内吞小泡中逃逸。在这里,我们重新设计了ZF5.3的序列,以加快内体逃逸的时间。我们描述的新小蛋白AV5.3在早期内吞途径中比ZF5.3更早逃逸,无论有无酶货物,效率都没有损失。更重要的是,更早的内体逃逸意味着到达胞质溶胶时pH敏感酶的酶活性更高。用AV5.3递送pH敏感酶二氢叶酸还原酶(DHFR)会在胞质溶胶中产生大量催化活性,而用ZF5.3递送则不会。递送的AV5.3-DHFR的活性成功挽救了CHO细胞中的DHFR缺失。AV5.3代表了一种用于有效和直接递送活性治疗性蛋白质和酶的改进策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/12022911/241150f63f79/oc5c00012_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验